TUB Antibody

What is the TUB protein and what function do TUB antibodies serve in research?

The TUB (tubby) protein is a bipartite transcription factor with a canonical length of 506 amino acids and a molecular mass of 55.7 kDa in humans. It exhibits complex subcellular localization, being present in the cell membrane, nucleus, cytoplasm, and is also secreted extracellularly. TUB functions primarily in signal transduction from heterotrimeric G protein-coupled receptors .

TUB antibodies are immunological tools designed specifically to detect and study this protein across various experimental contexts. They enable researchers to:

• Visualize TUB expression patterns within tissues and cells

• Quantify TUB protein levels in biological samples

• Investigate protein-protein interactions involving TUB

• Study subcellular localization and trafficking of TUB

• Examine alterations in TUB expression in disease states

What are the common experimental applications for TUB antibodies?

TUB antibodies demonstrate versatility across multiple immunological techniques:

These applications are instrumental in understanding TUB's role in both normal physiology and pathological conditions .

What species reactivity is available for TUB antibodies?

TUB is evolutionarily conserved, with orthologs reported across diverse species. Commercially available antibodies exhibit reactivity with:

• Human (Hu)

• Mouse (Ms)

• Rat (Rt)

• Bovine (Bv)

• Drosophila (Dr)

• Zebrafish

• Chimpanzee

• Chicken

• Frog

This cross-reactivity is particularly valuable for comparative studies across model organisms. When selecting antibodies for cross-species applications, researchers should verify epitope conservation in the target species .

How should researchers validate the specificity of TUB antibodies?

Validating antibody specificity is crucial for experimental rigor. For TUB antibodies, consider these validation approaches:

• Positive and negative controls: Use tissues or cell lines with known TUB expression patterns. Include TUB-knockout cells when available.

• Peptide competition: Pre-incubate the antibody with excess TUB peptide antigen before application to demonstrate binding specificity.

• Multiple antibody validation: Use at least two different antibodies targeting distinct epitopes.

• siRNA knockdown: Confirm signal reduction following TUB knockdown.

• Western blot molecular weight verification: Confirm the detected band matches the expected molecular weight (55.7 kDa for canonical TUB) .

What are optimal sample preparation protocols for TUB antibody applications?

Sample preparation significantly impacts TUB antibody performance:

For Western Blot:

• Lyse cells in RIPA buffer with protease inhibitors

• Include phosphatase inhibitors when studying TUB phosphorylation

• Sonicate briefly to shear DNA and reduce sample viscosity

• Heat samples at 95°C for 5 minutes in reducing buffer

For Immunohistochemistry:

• 4% paraformaldehyde fixation (12-24 hours)

• Mild antigen retrieval (citrate buffer, pH 6.0)

• Block with 5-10% normal serum from the species of secondary antibody

For Immunofluorescence:

• 4% paraformaldehyde (10-15 minutes)

• 0.1-0.2% Triton X-100 permeabilization (5-10 minutes)

• BSA/normal serum blocking (30-60 minutes)

How can researchers troubleshoot weak or inconsistent TUB antibody signals?

How do TUB antibodies help elucidate G protein-coupled receptor signaling pathways?

TUB functions in signal transduction from heterotrimeric G protein-coupled receptors (GPCRs). TUB antibodies enable researchers to:

• Co-immunoprecipitation studies: Identify GPCR partners that interact with TUB by immunoprecipitating with TUB antibodies followed by mass spectrometry or Western blot.

• Phosphorylation-specific antibodies: Detect post-translational modifications of TUB that occur during GPCR activation.

• Proximity ligation assays: Visualize direct interactions between TUB and GPCRs in situ using TUB antibodies paired with GPCR-specific antibodies.

• Subcellular fractionation validation: Track TUB translocation during GPCR signaling using antibodies to detect redistribution between membrane, cytoplasmic, and nuclear fractions.

• Chromatin immunoprecipitation (ChIP): Identify genomic targets of TUB following GPCR activation, utilizing TUB's role as a transcription factor .

What is the Tub-tag conjugation technology and how does it advance antibody applications?

Tub-tag represents a significant innovation in antibody engineering:

Tub-tag is a 14 amino acid peptide (VDSVEGEGEEEGEE) derived from the C-terminus of α-tubulin. This highly negatively charged sequence creates a favorable hydrophilic microenvironment that can be exploited for site-specific conjugation of hydrophobic moieties. The technology enables:

• Site-specific conjugation: The enzyme tubulin tyrosine ligase (TTL) catalyzes the addition of tyrosine derivatives to the C-terminal Tub-tag sequence.

• Homogeneous antibody-drug conjugates (ADCs): Tub-tag technology produces ADCs with precise drug-to-antibody ratios (DAR), as demonstrated with TUB-010, a next-generation CD30-targeting ADC.

• Enhanced stability: ADCs created using Tub-tag technology show significantly improved stability with minimal premature payload deconjugation compared to conventional conjugation methods.

• Improved pharmacokinetics: The hydrophilic nature of the Tub-tag helps maintain antibody-like pharmacokinetics even after conjugation with hydrophobic drug molecules.

• Reduced toxicity: The precision of Tub-tag conjugation results in lower non-specific cytotoxicity and improved tolerability in preclinical models .

How can TUB antibodies be employed to study TUB's association with retinal dystrophy and obesity?

TUB gene mutations have been linked to retinal dystrophy and obesity, making TUB antibodies valuable tools for investigating these conditions:

For retinal studies:

• Immunohistochemical mapping of TUB expression across retinal layers in normal versus diseased states

• Co-localization with retinal cell-type specific markers to identify affected cell populations

• Quantitative analysis of TUB levels in retinal tissues from disease models

• Investigation of TUB interaction partners specific to retinal physiology

For obesity research:

• Analysis of TUB expression in hypothalamic regions controlling appetite

• Comparison of TUB levels across metabolically relevant tissues in lean versus obese models

• Evaluation of post-translational modifications of TUB in response to metabolic stimuli

• Identification of TUB-regulated transcriptional networks in adipose tissue

What factors should researchers consider when selecting between different TUB antibody formats?

What are the critical parameters for validating new lots of TUB antibodies?

Rigorous quality control is essential when transitioning to new antibody lots:

• Side-by-side comparison: Run parallel experiments with both old and new lots using identical conditions.

• Titration analysis: Determine optimal working dilution for the new lot, which may differ from the previous lot.

• Signal-to-noise evaluation: Compare specific signal intensity versus background across multiple sample types.

• Epitope mapping confirmation: Verify that the new lot recognizes the same epitope region through peptide competition or epitope mapping experiments.

• Cross-reactivity assessment: Test against samples known to contain TUB homologs or related proteins.

• Application-specific validation: Validate specifically for each intended application (WB, IHC, IF, etc.).

• Documentation: Maintain detailed records of lot-to-lot performance differences for laboratory reference .

How can TUB antibodies be incorporated into multiplex immunoassay systems?

Multiplex detection strategies using TUB antibodies:

• Antibody conjugation options:

  • Fluorophore-labeled TUB antibodies with spectrally distinct emissions

  • Metal-tagged antibodies for mass cytometry (CyTOF)

  • Barcode-conjugated antibodies for sequential detection

• Platform compatibility:

  • Multiplexed immunofluorescence microscopy

  • Multi-parameter flow cytometry

  • Protein array technologies

  • Digital spatial profiling

• Optimization requirements:

  • Cross-reactivity testing with other antibodies in the panel

  • Titration within the multiplex context

  • Signal compensation and spillover correction

  • Careful selection of compatible fixation protocols

What are the key considerations for using TUB antibodies in studies of protein-protein interactions?

TUB protein interactions can be effectively studied using antibody-based approaches:

• Co-immunoprecipitation (Co-IP):

  • Use TUB antibodies to pull down protein complexes

  • Verify antibody does not disrupt interaction interfaces

  • Include appropriate controls: IgG isotype, reverse Co-IP

• Proximity ligation assay (PLA):

  • Pair TUB antibody with antibody against suspected interacting partner

  • Requires antibodies from different host species

  • Controls should include single antibody conditions

• FRET/BRET applications:

  • Use TUB antibodies to validate energy transfer results

  • Confirm that antibody binding doesn't alter protein conformation

• Crosslinking strategies:

  • Apply chemical crosslinkers before immunoprecipitation with TUB antibodies

  • Optimize crosslinker concentration and reaction time to capture transient interactions